BIOCORP This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Biocorp specializes in the development and manufacture of medical devices and drug delivery systems. The company offers traditional delivery systems, connected injection systems and monitoring devices.
Net sales break down by source of income between sales of services (86.9%) and products (13.1%).
At the end of 2022, Biocorp has a production site located in France.
France accounts for 62.6% of net sales.
Calendar
2024-09-25
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +7.71% | 218B | |
| +6.25% | 182B | |
| +10.60% | 132B | |
| +26.73% | 108B | |
| -0.65% | 62.51B | |
| +15.42% | 52.98B | |
| -1.89% | 47.59B | |
| -1.91% | 39.96B | |
| +11.16% | 39.22B |
